Contact this trialFirst, we need to learn more about you.
BTK Inhibitor
LOXO-305 for Chronic Lymphocytic Leukemia
Recruiting2 awardsPhase 3
Beverly Hills, California
This trial is for people with CLL or SLL who have had treatment with a BTK inhibitor. They will compare LOXO-305 to idelalisib plus rituximab or bendamustine plus rituximab.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service